| whiBioMarker {TwoPhaseInd} | R Documentation |
An example dataset to demostrate the usage of MELE and SPMLE
Description
A dataset from a Women's Health Initiative (WHI) hormone trial to study the interaction between biomarker and hormone therapy on stroke.
Usage
data("whiBioMarker")
Format
A data frame consisting of 10 observations, with the following columns:
strokea binary indicator vector of stroke; 1=has stroke
hrtdispa binary indicator vector of treatment in the Estrogen Plus Progestin Trial; 1="Estrogen Plus Progestin", 0="placebo"
papbla numeric vector of Biomarker PAP (plasmin-antiplasmin complex) in logarithmic scale (base 10)
agean integer vector of age
diasA binary indicator vector of Diastolic BP; 1="Yes"
hypa vector of hypertension with levels
Missing,No,Yessystan integer vector of Systolic BP
diabtrtA vector of Diabetes with levels:
Missing,No,YeslmsepiA vector of episodes per week of moderate and strenuous recreational physical activity of >= 20 minutes duration with levels
2 - <4 episodes per week,4+ episodes per week,Missing,No activity,Some activityphasea numeric vector of phase; 1: phase 1, 2:phase 2
Details
It is an two-phase sampling example dataset adapted from Kooperberg et al. (2007) to demostrate the usage of MELE and SPMLE algorithms in Dai et al. (2009).
Source
C. Kooperberg, M. Cushman, J. Hsia, J. G. Robinson, A. K. Aragaki, J. K. Lynch, A. E. Baird, K. C. Johnson, L. H. Kuller, S. A. Beresford, and B. Rodriguez. Can biomarkers identify women at increased stroke risk? the women's health initiative hormone trials. PLoS clinical trials, 2(6):e28, Jun 15 2007.
References
J. Y. Dai, M. LeBlanc, and C. Kooperberg. Semiparametric estimation exploiting co-variate independence in two-phase randomized trials. Biometrics, 65(1):178-187, 2009.
Examples
data(whiBioMarker)
str(whiBioMarker)
colnames(whiBioMarker)